SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and ...

Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

Investing.com -- 在宣布向欧洲药品管理局提交高剂量肥胖治疗药物Wegovy的批准申请后，诺和诺德公司 (NYSE: NVO )股价上涨1%。

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...

纽约 - WW International, Inc.（即WeightWatchers）周二宣布与诺和诺德公司扩大合作，将在2025年7月以299美元的优惠价格为WeightWatchers诊所会员提供FDA批准的Wegovy（司美格鲁肽）注射剂，相当于节省200美元。根据 InvestingPro ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

The recent approval of weight-loss drug Wegovy in New Zealand has been hyped as a breakthrough in the country’s fight against ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.